Datum Källa Rubrik Typ Alternativ
2024-03-28 Penser Access by Carnegie Penser Access by Carnegie: Intervju med Spago Nanomedical - Carnegie Investment Bank - 28 mar 2024 Pressreleaser Visa Stäng
2024-03-27 Spago BioStock: Spago Nanomedical's CEO: "huge commercial opportunities are unfolding" Pressreleaser Visa Stäng
2024-02-09 Spago BioStock: 2023 springboard for Spago's radionuclide cancer therapy Pressreleaser Visa Stäng
2024-02-08 Penser Access by Carnegie Penser Access by Carnegie: Spago Nanomedical - Lockande nyhetsagenda Pressreleaser Visa Stäng
2024-02-08 Redeye Redeye: Spago Nanomedical Q4 Update Pressreleaser Ladda ner | Visa Stäng
2024-02-07 Spago Nanomedical Spago Nanomedical year-end report January-December, 2023 Rapporter Ladda ner | Visa Stäng
2024-02-07 Spago Nanomedical Spago Nanomedical bokslutskommuniké januari-december 2023 Rapporter Ladda ner | Visa Stäng
2024-01-25 Spago Nanomedical The rights issue and the directed share issue to certain guarantors in Spago Nanomedical fully registered Pressreleaser Ladda ner | Visa Stäng
2024-01-25 Spago Nanomedical Företrädesemissionen och den riktade emissionen till vissa garanter i Spago Nanomedical slutregistrerade Pressreleaser Ladda ner | Visa Stäng
2024-01-18 Spago Nanomedical Spago Nanomedical presenterar på Redeyes temadag Fight Cancer den 24 januari Pressreleaser Ladda ner | Visa Stäng
2024-01-18 Spago Nanomedical Spago Nanomedical presents at Redeye’s Fight Cancer event on January 24 Pressreleaser Ladda ner | Visa Stäng
2024-01-15 Spago BioStock: Spago's phase I/IIa cancer trial progressing steadily Pressreleaser Visa Stäng
2024-01-10 Spago Nanomedical Spago Nanomedical går vidare till nästa dosnivå i fas I/IIa-studien Tumorad-01 Pressreleaser Ladda ner | Visa Stäng
2024-01-10 Spago Nanomedical Spago Nanomedical proceeds to the next dose level in the phase I/IIa study Tumorad-01 Pressreleaser Ladda ner | Visa Stäng
2024-01-03 Redeye Redeye: Spago Nanomedical - Update after funding and initiation of Tumorad Pressreleaser Ladda ner | Visa Stäng
2023-12-20 Spago BioStock: Positive data in Spago's phase IIa endometriosis trial Pressreleaser Visa Stäng
2023-12-18 Penser Access by Carnegie Penser Access by Carnegie: Spago Nanomedical - Uppmuntrande resultat Pressreleaser Visa Stäng
2023-12-15 Spago Nanomedical Spago Nanomedical reports positive top line data from clinical phase IIa study SPAGOPIX-02 in patients with endometriosis Pressreleaser Ladda ner | Visa Stäng
2023-12-15 Spago Nanomedical Spago Nanomedical rapporterar positiva topline-data från den kliniska fas 2a studien SPAGOPIX-02 i patienter med endometrios Pressreleaser Ladda ner | Visa Stäng
2023-12-14 Penser Access by Carnegie Penser Access by Carnegie: Intervju med Spago Nanomedical - Carnegie Investment Bank - 14 dec 2023 Pressreleaser Visa Stäng
2023-12-14 Spago BioStock: First patient dosed in Spago's phase I/IIa trial Pressreleaser Visa Stäng
2023-12-13 Spago Nanomedical Spago Nanomedical carries out a directed issue of shares to guarantors following the completed rights issue Pressreleaser Ladda ner | Visa Stäng
2023-12-13 Spago Nanomedical Spago Nanomedical genomför riktad nyemission av aktier till garanter efter den genomförda företrädesemissionen Pressreleaser Ladda ner | Visa Stäng
2023-12-12 Spago Nanomedical Företrädesemissionen i Spago Nanomedical delregistrerad Pressreleaser Ladda ner | Visa Stäng
2023-12-12 Spago Nanomedical Rights issue in Spago Nanomedical partially registered Pressreleaser Ladda ner | Visa Stäng
2023-12-07 Spago Nanomedical First patient dosed in Spago Nanomedical's clinical phase I/IIa study within the Tumorad® program Pressreleaser Ladda ner | Visa Stäng
2023-12-07 Spago Nanomedical Första patienten doserad i Spago Nanomedicals kliniska fas I/IIa-studie inom Tumorad®-programmet Pressreleaser Ladda ner | Visa Stäng
2023-11-27 Spago Nanomedical Spago Nanomedical announces outcome of the rights issue Pressreleaser Ladda ner | Visa Stäng
2023-11-27 Spago Nanomedical Spago Nanomedical offentliggör utfall i företrädesemissionen Pressreleaser Ladda ner | Visa Stäng
2023-11-23 Spago Nanomedical Last day of the subscription period in Spago Nanomedical’s rights issue Pressreleaser Ladda ner | Visa Stäng
2023-11-23 Spago Nanomedical Sista dagen i teckningsperioden i Spago Nanomedicals företrädesemission Pressreleaser Ladda ner | Visa Stäng
2023-11-14 Spago Nanomedical Valberedning utsedd inför Spago Nanomedicals årsstämma 2024 Pressreleaser Ladda ner | Visa Stäng
2023-11-14 Spago Nanomedical Nomination committee appointed for Spago Nanomedical’s Annual General Meeting 2024 Pressreleaser Ladda ner | Visa Stäng
2023-11-09 Spago Nanomedical The subscription period in Spago Nanomedical’s rights issue begins today Pressreleaser Ladda ner | Visa Stäng
2023-11-09 Spago Nanomedical Idag börjar teckningsperioden i Spago Nanomedicals företrädesemission Pressreleaser Ladda ner | Visa Stäng
2023-11-08 Penser Access Penser Access: Betydelsefullt stöd från huvudägare - Spago Nanomedical Pressreleaser Visa Stäng
2023-11-07 Spago Nanomedical Spago Nanomedical offentliggör prospekt med anledning av förestående företrädesemission Pressreleaser Ladda ner | Visa Stäng
2023-11-07 Spago Nanomedical Spago Nanomedical publishes prospectus in connection with forthcoming rights issue Pressreleaser Ladda ner | Visa Stäng
2023-11-03 Spago Nanomedical Spago Nanomedical delårsrapport januari-september 2023 Rapporter Ladda ner | Visa Stäng
2023-11-03 Spago Nanomedical Spago Nanomedical interim report January-September 2023 Rapporter Ladda ner | Visa Stäng
2023-10-31 Spago Nanomedical Bulletin from the Extraordinary General Meeting of Spago Nanomedical AB on 31 October 2023 Pressreleaser Ladda ner | Visa Stäng
2023-10-31 Spago Nanomedical Kommuniké från extra bolagsstämma i Spago Nanomedical AB den 31 oktober 2023 Pressreleaser Ladda ner | Visa Stäng
2023-10-30 Spago Spago: BioStock: Tumorad's potential in transforming cancer care Pressreleaser Visa Stäng
2023-10-30 Spago Spago: BioStock: Tumorad's potential in transforming cancer care Pressreleaser Visa Stäng
2023-10-24 Spago Nanomedical Spago Nanomedical ansöker om utökat patentskydd för Tumorad® Pressreleaser Ladda ner | Visa Stäng
2023-10-24 Spago Nanomedical Spago Nanomedical applies for extended patent protection for Tumorad® Pressreleaser Ladda ner | Visa Stäng
2023-10-23 Spago BioStock: Spago Nanomedical's promising cancer therapy approved for phase I/IIa Pressreleaser Visa Stäng
2023-10-19 Spago Nanomedical Spago Nanomedical receives approval to initiate the clinical phase I/IIa study with Tumorad® in Australia Pressreleaser Ladda ner | Visa Stäng
2023-10-19 Spago Nanomedical Spago Nanomedical får klartecken att starta klinisk fas I/IIa-studie med Tumorad® i Australien Pressreleaser Ladda ner | Visa Stäng
2023-10-18 Spago Spago Nanomedical presenterar på BioStock Life Science Summit den 25 oktober Pressreleaser Visa Stäng
2023-10-11 Penser Access Penser Access: Intervju med Spago Nanomedical - Erik Penser Bank - 11 oktober 2023 Pressreleaser Visa Stäng
2023-10-05 Spago Nanomedical Notice to the Extraordinary General Meeting of Spago Nanomedical AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-10-05 Spago Nanomedical Kallelse till extra bolagsstämma i Spago Nanomedical AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-10-05 Spago Nanomedical Spago Nanomedical proposes a fully guaranteed rights issue of units of approximately SEK 30.6 million to advance Tumorad Pressreleaser Ladda ner | Visa Stäng
2023-10-05 Spago Nanomedical Spago Nanomedical föreslår en fullt garanterad företrädesemission av units om cirka 30,6 MSEK för att avancera Tumorad Pressreleaser Ladda ner | Visa Stäng
2023-08-14 Penser Access Penser Access: Sticker ut i mängden - Spago Nanomedical Pressreleaser Visa Stäng
2023-08-01 Redeye Redeye: Spago Nanomedical Q2 - Milestone almost concluded, continued cost control crucial Pressreleaser Ladda ner | Visa Stäng
2023-07-31 Spago Nanomedical Spago Nanomedical delårsrapport januari-juni 2023 Rapporter Ladda ner | Visa Stäng
2023-07-31 Spago Nanomedical Spago Nanomedical interim report January-June 2023 Rapporter Ladda ner | Visa Stäng
2023-06-29 Spago BioStock: Spago Nanomedical's SAB on Tumorad's potential Pressreleaser Visa Stäng
2023-06-28 Spago Nanomedical Spago Nanomedical uppdaterar om den kliniska fas IIa-studien SPAGOPIX-02 Pressreleaser Ladda ner | Visa Stäng
2023-06-28 Spago Nanomedical Spago Nanomedical updates on the clinical phase IIa study SPAGOPIX-02 Pressreleaser Ladda ner | Visa Stäng
2023-06-13 Spago Nanomedical Spago Nanomedical stärker Tumorad® genom nytt vetenskapligt råd Pressreleaser Ladda ner | Visa Stäng
2023-06-13 Spago Nanomedical Spago Nanomedical strengthens Tumorad® by establishment of Scientific Advisory Board Pressreleaser Ladda ner | Visa Stäng
2023-05-30 Spago BioStock: Spago Nanomedicals CDO om studieansökan Pressreleaser Visa Stäng
2023-05-30 Spago BioStock: Spago Nanomedical's CDO on study submission Pressreleaser Visa Stäng
2023-05-23 Spago Nanomedical Spago Nanomedical has submitted application to start Tumorad® clinical phase I/IIa study Pressreleaser Ladda ner | Visa Stäng
2023-05-23 Spago Nanomedical Spago Nanomedical har lämnat in ansökan om att starta klinisk fas I/IIa-studie med Tumorad® Pressreleaser Ladda ner | Visa Stäng
2023-05-16 Spago BioStock: Tumorad clinical start around the corner for Spago Nanomedical Pressreleaser Visa Stäng
Pressreleaser | 16 May 2023 | Spago Nanomedical

BioStock: Tumorad clinical start around the corner for Spago Nanomedical

Read the interview with Spago Nanomedical’s CEO Mats Hansen at biostock.se:

https://www.biostock.se/en/2023/05/tumorad-clinical-start-around-the-corner-for-spago-nanomedical/

This is a press release from BioStock – Connecting Innovation & Capital.  https://www.biostock.se/en/

2023-05-11 Redeye Redeye: Spago Nanomedical - Pivotal year ahead Pressreleaser Ladda ner | Visa Stäng
2023-05-10 Spago Nanomedical Kommuniké från årsstämma 2023 i Spago Nanomedical AB Pressreleaser Ladda ner | Visa Stäng
2023-05-10 Spago Nanomedical Bulletin from the 2023 Annual General Meeting of Spago Nanomedical AB Pressreleaser Ladda ner | Visa Stäng
2023-05-09 Spago Nanomedical Spago Nanomedical delårsrapport januari-mars 2023 Rapporter Ladda ner | Visa Stäng
2023-05-09 Spago Nanomedical Spago Nanomedical interim report January-March 2023 Rapporter Ladda ner | Visa Stäng
2023-05-04 Spago Nanomedical Presentation of Spago Nanomedical's clinical phase IIa study in endometriosis at the 15th World Congress of Endometriosis Pressreleaser Ladda ner | Visa Stäng
2023-05-04 Spago Nanomedical Presentation av Spago Nanomedicals kliniska fas IIa-studie i endometrios vid 15th World Congress of Endometriosis Pressreleaser Ladda ner | Visa Stäng
2023-04-05 Spago Nanomedical Kallelse till årsstämma i Spago Nanomedical AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-04-05 Spago Nanomedical Notice to Annual General Meeting of Spago Nanomedical AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-04-04 Spago Nanomedical The nomination committee proposes changes to the board of Spago Nanomedical for increased commercial focus Pressreleaser Ladda ner | Visa Stäng
2023-04-04 Spago Nanomedical Valberedningen föreslår förändringar i styrelsen för Spago Nanomedical för ökat kommersiellt fokus Pressreleaser Ladda ner | Visa Stäng
2023-03-29 Spago Nanomedical Spago Nanomedical publicerar årsredovisningen för 2022 Rapporter Ladda ner | Visa Stäng
2023-03-29 Spago Nanomedical Spago Nanomedical publishes the annual report for 2022 Rapporter Ladda ner | Visa Stäng

Kommande händelser

2 May 2024 | Kvartalsrapport 2024-Q1
10 Jun 2024 | Årsstämma 2023
11 Jun 2024 | Årligutdelning
21 Aug 2024 | Kvartalsrapport 2024-Q2
6 Nov 2024 | Kvartalsrapport 2024-Q3